Will a U.S.-India Working Group do the Bidding of the Pharma Industry? – Pharmalot – WSJ
0
After a meeting last week between President Barack Obama and the recently elected Indian Prime Minister Narenrda Modi, the White House issued a statement that included a brief passage saying a new “high level” working group on intellectual property was being created.
The statement prompted concern from advocacy groups that closely track the contentious interplay between access to affordable medicines and pharmaceutical patents. In their view, the initiative may become a tool for pressuring India to change its approach to patent law
Why? India is something of a pharmacy to the world, because so many generic drug makers are based there. Moreover, India has also irked brand-name drug makers with laws and court rulings that have made it easier for their generic rivals to sell lower-cost, copycat versions of their medicines.
This has generated concern in Washington…
Read more – Pharmalot – WSJ